Functional NHE1 expression is critical to blood brain barrier integrity and sumatriptan blood to brain uptake
Authors:
- Erika Liktor-BusaErika Liktor-Busa
- Kiera T. BlawnKBKiera T. Blawn
- Kathryn L. KellohenKKKathryn L. Kellohen
- Beth M. WieseBWBeth M. Wiese
- Vani VerkhovskyVVVani Verkhovsky
- Jared WahlJWJared Wahl
- Anjali VivekAVAnjali Vivek
- Thomas P. DavisTDThomas P. Davis
- Todd W. VanderahTVTodd W. Vanderah
- Tally M. Largent-MilnesTLTally M. Largent-Milnes
Preprint
- 20 December 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
Abstract
Disruption of blood-brain barrier integrity and dramatic failure of brain ion homeostasis including fluctuations of pH occurs during cortical spreading depression (CSD) events associated with several neurological disorders, including migraine with aura, traumatic brain injury and stroke. NHE1 is the primary regulator of pH in the central nervous system. The goal of the current study was to investigate the role of sodium-hydrogen exchanger type 1 (NHE1) in blood brain barrier (BBB) integrity during CSD events and the contributions of this antiporter on xenobiotic uptake. Using immortalized cell lines, pharmacologic inhibition and genetic knockdown of NHE1 mitigated the paracellular uptake of radiolabeled sucrose implicating functional NHE1 in BBB maintenance. In contrast, loss of functional NHE1 in endothelial cells facilitated uptake of the anti-migraine therapeutic, sumatriptan. In female rats, cortical KCl but not aCSF selectively reduced total expression of NHE1 in cortex and PAG with limited impact on trigeminal ganglia or trigeminal nucleus caudalis suggesting in vitro observations may have a significancein vivo. Pharmacological inhibition of NHE1 prior to cortical manipulations enhanced the efficacy of sumatriptan at early time-points but induced facial sensitivity alone. Overall, our results suggest that dysregulation of NHE1 contributes to breaches in BBB integrity, drug penetrance, and the behavioral sensitivity to the antimigraine agent, sumatriptan.Keywords
All Related Versions
- Published version: PLOS ONE, 15 (5), e0227463.
This publication has 86 references indexed in Scilit:
- Cortical spreading depression as a target for anti-migraine agentsThe Journal of Headache and Pain, 2013
- Role of NHE1 in NociceptionPain Research and Treatment, 2013
- The blood-brain barrier: an engineering perspectiveFrontiers in Neuroengineering, 2013
- Role of sodium/hydrogen exchanger isoform 1 in microglial activation and proinflammatory responses in ischemic brainsJournal of Neurochemistry, 2011
- Altered functional magnetic resonance imaging resting‐state connectivity in periaqueductal gray networks in migraineAnnals of Neurology, 2011
- Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain InjuryJournal of Cerebral Blood Flow & Metabolism, 2010
- Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with AuraThe Journal of Neuroscience, 2010
- Pericyte-mediated regulation of capillary diameter: a component of neurovascular coupling in health and diseaseFrontiers in Neuroenergetics, 2010
- Cerebral microvascular endothelial cell Na/H exchange: evidence for the presence of NHE1 and NHE2 isoforms and regulation by arginine vasopressinAmerican Journal of Physiology-Cell Physiology, 2009
- Medullary pain facilitating neurons mediate allodynia in headache‐related painAnnals of Neurology, 2009